杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/02/14 | 1,853 | 1,864 | 1,842 | 1,858 | ±0 | ±0% | 56,900 |
| 2022/02/10 | 1,855 | 1,865 | 1,846 | 1,858 | +15 | +0.8% | 48,700 |
| 2022/02/09 | 1,847 | 1,853 | 1,836 | 1,843 | ±0 | ±0% | 52,000 |
| 2022/02/08 | 1,861 | 1,866 | 1,838 | 1,843 | -14 | -0.8% | 65,300 |
| 2022/02/07 | 1,848 | 1,865 | 1,834 | 1,857 | +3 | +0.2% | 98,000 |
| 2022/02/04 | 1,848 | 1,854 | 1,833 | 1,854 | +16 | +0.9% | 77,400 |
| 2022/02/03 | 1,832 | 1,847 | 1,822 | 1,838 | -3 | -0.2% | 83,800 |
| 2022/02/02 | 1,822 | 1,845 | 1,817 | 1,841 | +25 | +1.4% | 84,600 |
| 2022/02/01 | 1,826 | 1,828 | 1,806 | 1,816 | -6 | -0.3% | 72,000 |
| 2022/01/31 | 1,837 | 1,837 | 1,788 | 1,822 | -9 | -0.5% | 118,200 |
| 2022/01/28 | 1,812 | 1,831 | 1,812 | 1,831 | +39 | +2.2% | 80,700 |
| 2022/01/27 | 1,800 | 1,802 | 1,776 | 1,792 | -24 | -1.3% | 153,300 |
| 2022/01/26 | 1,835 | 1,835 | 1,810 | 1,816 | -22 | -1.2% | 49,100 |
| 2022/01/25 | 1,850 | 1,850 | 1,820 | 1,838 | -7 | -0.4% | 80,700 |
| 2022/01/24 | 1,803 | 1,849 | 1,803 | 1,845 | +24 | +1.3% | 79,800 |
| 2022/01/21 | 1,791 | 1,827 | 1,780 | 1,821 | +22 | +1.2% | 114,100 |
| 2022/01/20 | 1,826 | 1,826 | 1,792 | 1,799 | -16 | -0.9% | 122,700 |
| 2022/01/19 | 1,809 | 1,822 | 1,798 | 1,815 | -11 | -0.6% | 85,300 |
| 2022/01/18 | 1,847 | 1,852 | 1,825 | 1,826 | ±0 | ±0% | 82,800 |
| 2022/01/17 | 1,843 | 1,843 | 1,815 | 1,826 | -9 | -0.5% | 29,900 |
| 2022/01/14 | 1,826 | 1,835 | 1,811 | 1,835 | +8 | +0.4% | 77,300 |
| 2022/01/13 | 1,820 | 1,831 | 1,813 | 1,827 | +5 | +0.3% | 70,500 |
| 2022/01/12 | 1,815 | 1,838 | 1,810 | 1,822 | +14 | +0.8% | 54,700 |
| 2022/01/11 | 1,813 | 1,813 | 1,786 | 1,808 | +9 | +0.5% | 52,700 |
| 2022/01/07 | 1,801 | 1,812 | 1,781 | 1,799 | -3 | -0.2% | 71,200 |
| 2022/01/06 | 1,820 | 1,834 | 1,799 | 1,802 | -29 | -1.6% | 66,100 |
| 2022/01/05 | 1,849 | 1,849 | 1,820 | 1,831 | -7 | -0.4% | 75,900 |
| 2022/01/04 | 1,842 | 1,848 | 1,826 | 1,838 | -8 | -0.4% | 78,700 |
| 2021/12/30 | 1,845 | 1,850 | 1,840 | 1,846 | +1 | +0.1% | 51,100 |
| 2021/12/29 | 1,838 | 1,857 | 1,829 | 1,845 | ±0 | ±0% | 75,800 |
| 2021/12/28 | 1,828 | 1,845 | 1,816 | 1,845 | +22 | +1.2% | 104,400 |
| 2021/12/27 | 1,815 | 1,824 | 1,791 | 1,823 | +12 | +0.7% | 68,500 |
| 2021/12/24 | 1,813 | 1,818 | 1,800 | 1,811 | +11 | +0.6% | 78,100 |
| 2021/12/23 | 1,810 | 1,810 | 1,787 | 1,800 | -10 | -0.6% | 78,900 |
| 2021/12/22 | 1,798 | 1,810 | 1,790 | 1,810 | +21 | +1.2% | 97,600 |
| 2021/12/21 | 1,796 | 1,799 | 1,782 | 1,789 | +15 | +0.8% | 78,400 |
| 2021/12/20 | 1,783 | 1,794 | 1,773 | 1,774 | -25 | -1.4% | 63,700 |
| 2021/12/17 | 1,797 | 1,808 | 1,786 | 1,799 | -7 | -0.4% | 131,800 |
| 2021/12/16 | 1,815 | 1,816 | 1,790 | 1,806 | +14 | +0.8% | 84,700 |
| 2021/12/15 | 1,790 | 1,803 | 1,783 | 1,792 | -7 | -0.4% | 62,300 |
| 2021/12/14 | 1,782 | 1,803 | 1,777 | 1,799 | +34 | +1.9% | 98,600 |
| 2021/12/13 | 1,800 | 1,800 | 1,761 | 1,765 | -28 | -1.6% | 64,400 |
| 2021/12/10 | 1,789 | 1,804 | 1,776 | 1,793 | +4 | +0.2% | 131,900 |
| 2021/12/09 | 1,804 | 1,809 | 1,787 | 1,789 | -6 | -0.3% | 208,400 |
| 2021/12/08 | 1,783 | 1,798 | 1,773 | 1,795 | +13 | +0.7% | 149,800 |
| 2021/12/07 | 1,743 | 1,783 | 1,741 | 1,782 | +52 | +3% | 113,200 |
| 2021/12/06 | 1,737 | 1,755 | 1,729 | 1,730 | -12 | -0.7% | 110,700 |
| 2021/12/03 | 1,692 | 1,742 | 1,685 | 1,742 | +59 | +3.5% | 124,000 |
| 2021/12/02 | 1,663 | 1,693 | 1,663 | 1,683 | +11 | +0.7% | 96,100 |
| 2021/12/01 | 1,675 | 1,675 | 1,662 | 1,672 | -16 | -0.9% | 100,700 |
801～
850
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 81,800円 | +20.3% | - | 0.00% | 145.04倍 | 1.08倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
